Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3625 | 1942 | 30.3 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
3625 | 1 | VALPROIC ACID//VALPROATE//VALNOCTAMIDE | 1942 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VALPROIC ACID | authKW | 1279660 | 20% | 21% | 392 |
2 | VALPROATE | authKW | 617843 | 12% | 17% | 228 |
3 | VALNOCTAMIDE | authKW | 181259 | 1% | 82% | 14 |
4 | VALPROMIDE | authKW | 162259 | 1% | 61% | 17 |
5 | TRANS 2 EN VALPROATE | authKW | 141497 | 0% | 100% | 9 |
6 | DAVID R BLOOM PHARM | address | 111419 | 2% | 16% | 44 |
7 | HYPERAMMONEMIA | authKW | 94446 | 3% | 9% | 64 |
8 | VALPROATE ENCEPHALOPATHY | authKW | 78610 | 0% | 100% | 5 |
9 | SODIUM VALPROATE | authKW | 78119 | 2% | 12% | 41 |
10 | 2 PROPYL 4 PENTENOIC ACID | authKW | 62888 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 7957 | 29% | 0% | 554 |
2 | Pharmacology & Pharmacy | 6123 | 34% | 0% | 656 |
3 | Toxicology | 1122 | 8% | 0% | 153 |
4 | Pediatrics | 1107 | 9% | 0% | 177 |
5 | Medical Laboratory Technology | 875 | 4% | 0% | 73 |
6 | Psychiatry | 559 | 7% | 0% | 139 |
7 | Neurosciences | 384 | 11% | 0% | 207 |
8 | Chemistry, Medicinal | 140 | 3% | 0% | 64 |
9 | Chemistry, Analytical | 133 | 5% | 0% | 99 |
10 | Medicine, General & Internal | 71 | 5% | 0% | 89 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DAVID R BLOOM PHARM | 111419 | 2% | 16% | 44 |
2 | R 4PK | 62888 | 0% | 100% | 4 |
3 | R4PK | 42790 | 0% | 39% | 7 |
4 | CLIN CHEM PAEDIAT | 37725 | 0% | 40% | 6 |
5 | EBN SINA HOSP | 31444 | 0% | 100% | 2 |
6 | FOOD TOXICOL CHEM ANAL FOOD TOXICOL | 31444 | 0% | 100% | 2 |
7 | ENVIRONM GENET MED | 29500 | 1% | 14% | 13 |
8 | STUDIES DRUG DISPOSIT | 24599 | 0% | 26% | 6 |
9 | TOXICOGENOM CONSORTIUM | 20961 | 0% | 67% | 2 |
10 | NAT PROD MED CHEM | 20525 | 0% | 15% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 38056 | 8% | 2% | 147 |
2 | EPILEPSY RESEARCH | 8528 | 2% | 1% | 46 |
3 | THERAPEUTIC DRUG MONITORING | 8084 | 2% | 1% | 44 |
4 | BIOPHARMACEUTICS & DRUG DISPOSITION | 5061 | 1% | 1% | 25 |
5 | JOURNAL DE MEDECINE DE STRASBOURG | 4739 | 0% | 8% | 4 |
6 | DRUG METABOLISM AND DISPOSITION | 2964 | 2% | 1% | 38 |
7 | PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION | 2743 | 1% | 2% | 10 |
8 | JOURNAL OF EPILEPSY | 2519 | 0% | 2% | 8 |
9 | JOURNAL OF CHILD NEUROLOGY | 2149 | 1% | 1% | 26 |
10 | NEUROLOGY | 2082 | 3% | 0% | 54 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VALPROIC ACID | 1279660 | 20% | 21% | 392 | Search VALPROIC+ACID | Search VALPROIC+ACID |
2 | VALPROATE | 617843 | 12% | 17% | 228 | Search VALPROATE | Search VALPROATE |
3 | VALNOCTAMIDE | 181259 | 1% | 82% | 14 | Search VALNOCTAMIDE | Search VALNOCTAMIDE |
4 | VALPROMIDE | 162259 | 1% | 61% | 17 | Search VALPROMIDE | Search VALPROMIDE |
5 | TRANS 2 EN VALPROATE | 141497 | 0% | 100% | 9 | Search TRANS+2+EN+VALPROATE | Search TRANS+2+EN+VALPROATE |
6 | HYPERAMMONEMIA | 94446 | 3% | 9% | 64 | Search HYPERAMMONEMIA | Search HYPERAMMONEMIA |
7 | VALPROATE ENCEPHALOPATHY | 78610 | 0% | 100% | 5 | Search VALPROATE+ENCEPHALOPATHY | Search VALPROATE+ENCEPHALOPATHY |
8 | SODIUM VALPROATE | 78119 | 2% | 12% | 41 | Search SODIUM+VALPROATE | Search SODIUM+VALPROATE |
9 | 2 PROPYL 4 PENTENOIC ACID | 62888 | 0% | 100% | 4 | Search 2+PROPYL+4+PENTENOIC+ACID | Search 2+PROPYL+4+PENTENOIC+ACID |
10 | VALPROIC ACID INTOXICATION | 62888 | 0% | 100% | 4 | Search VALPROIC+ACID+INTOXICATION | Search VALPROIC+ACID+INTOXICATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LHEUREUX, PER , HANTSON, P , (2009) CARNITINE IN THE TREATMENT OF VALPROIC ACID-INDUCED TOXICITY.CLINICAL TOXICOLOGY. VOL. 47. ISSUE 2. P. 101 -111 | 74 | 94% | 74 |
2 | SILVA, MFB , AIRES, CCP , LUIS, PBM , RUITER, JPN , IJIST, L , DURAN, M , WANDERS, RJA , DE ALMEIDA, IT , (2008) VALPROIC ACID METABOLISM AND ITS EFFECTS ON MITOCHONDRIAL FATTY ACID OXIDATION: A REVIEW.JOURNAL OF INHERITED METABOLIC DISEASE. VOL. 31. ISSUE 2. P. 205 -216 | 66 | 75% | 108 |
3 | LHEUREUX, PER , PENALOZA, A , ZAHIR, S , GRIS, M , (2005) SCIENCE REVIEW: CARNITINE IN THE TREATMENT OF VALPROIC ACID-INDUCED TOXICITY - WHAT IS THE EVIDENCE?.CRITICAL CARE. VOL. 9. ISSUE 5. P. 431-440 | 57 | 90% | 70 |
4 | FRYE, MA , CHOPRA, A , KOLLA, BP , MANSUKHANI, MP , NETZEL, P , (2012) VALPROATE-INDUCED HYPERAMMONEMIC ENCEPHALOPATHY: AN UPDATE ON RISK FACTORS, CLINICAL CORRELATES AND MANAGEMENT.GENERAL HOSPITAL PSYCHIATRY. VOL. 34. ISSUE 3. P. 290 -298 | 47 | 90% | 16 |
5 | LOSCHER, W , (1999) VALPROATE: A REAPPRAISAL OF ITS PHARMACODYNAMIC PROPERTIES AND MECHANISMS OF ACTION.PROGRESS IN NEUROBIOLOGY. VOL. 58. ISSUE 1. P. 31 -59 | 86 | 51% | 321 |
6 | SZTAJNKRYCER, MD , (2002) VALPROIC ACID TOXICITY: OVERVIEW AND MANAGEMENT.JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY. VOL. 40. ISSUE 6. P. 789-801 | 60 | 78% | 102 |
7 | MANOGUERRA, AS , ERDMAN, AR , WOOLF, AD , CHYKA, PA , CARAVATI, EM , SCHARMAN, EJ , BOOZE, LL , CHRISTIANSON, G , NELSON, LS , COBAUGH, DJ , ET AL (2008) VALPROIC ACID POISONING: AN EVIDENCE-BASED CONSENSUS GUIDELINE FOR OUT-OF-HOSPITAL MANAGEMENT.CLINICAL TOXICOLOGY. VOL. 46. ISSUE 7. P. 661 -676 | 45 | 92% | 8 |
8 | GHANNOUM, M , LALIBERTE, M , NOLIN, TD , MACTIER, R , LAVERGNE, V , HOFFMAN, RS , GOSSELIN, S , (2015) EXTRACORPOREAL TREATMENT FOR VALPROIC ACID POISONING: SYSTEMATIC REVIEW AND RECOMMENDATIONS FROM THE EXTRIP WORKGROUP.CLINICAL TOXICOLOGY. VOL. 53. ISSUE 5. P. 454 -465 | 50 | 62% | 2 |
9 | COTARIU, D , ZAIDMAN, JL , (1988) VALPROIC ACID AND THE LIVER.CLINICAL CHEMISTRY. VOL. 34. ISSUE 5. P. 890-897 | 83 | 78% | 50 |
10 | REED, RC , DUTTA, S , LIU, W , (2009) ONCE-DAILY DOSING IS APPROPRIATE FOR EXTENDED-RELEASE DIVALPROEX OVER A WIDE DOSE RANGE, BUT NOT FOR ENTERIC-COATED, DELAYED-RELEASE DIVALPROEX: EVIDENCE VIA COMPUTER SIMULATIONS AND IMPLICATIONS FOR EPILEPSY THERAPY.EPILEPSY RESEARCH. VOL. 87. ISSUE 2-3. P. 260 -267 | 40 | 78% | 5 |
Classes with closest relation at Level 1 |